LB

Labomar SpAMIL Labomar Stock Report

Last reporting period 31 Dec, 2022

Updated —

Last price

Market cap $B

0.148

Micro

Exchange

XMIL - Borsa Italiana S.P.A.

LBM.MI Stock Analysis

LB

Uncovered

Labomar SpA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

44/100

Low score

Market cap $B

0.148

Dividend yield

Shares outstanding

18.484 B

Labomar SpA operates as a contract development manufacturing organization which specializes in the research, development, and production of food supplements, medical equipment, food for special medical purposes, and cosmetics on behalf of third parties. The company is headquartered in Treviso, Treviso and currently employs 342 full-time employees. The company went IPO on 2020-10-05. is an Italy-based company, which produces dietary supplements, in either solid format or as liquids. The firm's oral solid products include chewable tablets, swallable tablets, coated tablets, gastro-resistant tablets, time release tablets, micro tablets, hard plant or animal gelatine capsules, oro dispersible powders, and water dispersible powders. Its oral liquid products include syrups, hydroglyceric and hydroalcoholic suspensions, solutions, emulsions, and nanoemulsions. The firm serves companies operating in the medical information sector, in distribution channels in chemist and herbalists shops, retail stores of products for athletes and retail organization.

View Section: Eyestock Rating